Member Exclusive News

The week in industry: Successful end to respiratory disease research collaboration

This week: Approval of combination treatment for NSCLC, €3.5 million milestone payment received in auto-immune disease collaboration and additional funding for the continued development of antifungal therapies.

Go to the profile of RxNet
Dec 05, 2019

Please sign in or register for FREE

No comments yet.